You just read:

Almirall and Forest Laboratories Announce FDA Approval of Tudorza™ Pressair™ for the Long-term Maintenance Treatment of COPD

News provided by

Almirall, S.A. and Forest Laboratories, Inc.

24 Jul, 2012, 08:50 BST